- Home
- ICCC vs SWVL Comparison
ICCC vs SWVL Comparison
Compare ICCC & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- SWVL
- Stock Information
- Founded
- ICCC 1982
- SWVL 2017
- Country
- ICCC United States
- SWVL United Arab Emirates
- Employees
- ICCC N/A
- SWVL N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- ICCC Health Care
- SWVL Consumer Discretionary
- Exchange
- ICCC Nasdaq
- SWVL Nasdaq
- Market Cap
- ICCC 48.3M
- SWVL 50.6M
- IPO Year
- ICCC 1987
- SWVL N/A
- Fundamental
- Price
- ICCC $5.07
- SWVL $3.06
- Analyst Decision
- ICCC
- SWVL
- Analyst Count
- ICCC 0
- SWVL 0
- Target Price
- ICCC N/A
- SWVL N/A
- AVG Volume (30 Days)
- ICCC 27.6K
- SWVL 9.8K
- Earning Date
- ICCC 05-14-2025
- SWVL 05-20-2025
- Dividend Yield
- ICCC N/A
- SWVL N/A
- EPS Growth
- ICCC N/A
- SWVL N/A
- EPS
- ICCC N/A
- SWVL N/A
- Revenue
- ICCC $26,493,169.00
- SWVL $17,207,362.00
- Revenue This Year
- ICCC N/A
- SWVL N/A
- Revenue Next Year
- ICCC N/A
- SWVL N/A
- P/E Ratio
- ICCC N/A
- SWVL N/A
- Revenue Growth
- ICCC 51.63
- SWVL N/A
- 52 Week Low
- ICCC $3.34
- SWVL $2.40
- 52 Week High
- ICCC $5.82
- SWVL $11.98
- Technical
- Relative Strength Index (RSI)
- ICCC 42.10
- SWVL 43.96
- Support Level
- ICCC $5.01
- SWVL $2.92
- Resistance Level
- ICCC $5.72
- SWVL $3.15
- Average True Range (ATR)
- ICCC 0.18
- SWVL 0.26
- MACD
- ICCC -0.05
- SWVL 0.05
- Stochastic Oscillator
- ICCC 14.96
- SWVL 28.48
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.